Orgenesis Inc (OTCPK:ORGS)
$ 2.9 0 (0%) Market Cap: 14.99 Mil Enterprise Value: 28.01 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 14/100

Orgenesis Inc at SNN Network Summer Event (Virtual) Transcript

Aug 19, 2021 / 12:00PM GMT
Release Date Price: $49.6 (-2.17%)
Operator

Good morning, everyone, and welcome to our first presentation and presenter of the day at the SNN Network Summer Virtual Event. I'm very pleased to introduce Vered Caplan, CEO of Orgenesis, publicly traded company, the symbol is ORGS on Nasdaq.

Vered, the floor is yours.

Vered Caplan
Orgenesis Inc. - CEO

Hi. Thank you, everyone, for coming to listen to the presentation. Wish it could be in person, but maybe next year.

So I wanted to present Orgenesis today, and we are a publicly traded company. So please read carefully the forward-looking statements.

And as I kind of tell you a little bit about the background of the Orgenesis, I just want to say that our focus is really cell and gene therapies. Cell and gene therapies is one of the fastest growing spaces in biotech. It's one of the most exciting spaces in biotech. And I don't know, I think the slides here are going a bit slow. I'll continue, and we'll start to resolve this as we go along.

And one of the things that we try to do is take this new space in biotech and make

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot